244 related articles for article (PubMed ID: 27423604)
41. [IgG4- and MPO-ANCA-associated hypertrophic pachymeningitis].
Aragonès JM; Arias-Rivero M; García-Barrionuevo JM; Lucchetti G
Rev Neurol; 2015 Nov; 61(10):454-7. PubMed ID: 26553176
[TBL] [Abstract][Full Text] [Related]
42. Hypertrophic Pachymeningitis in a Southern Chinese Population: A Retrospective Study.
Xiao X; Fu D; Feng L
Front Neurol; 2020; 11():565088. PubMed ID: 33281701
[No Abstract] [Full Text] [Related]
43. Effective cochlear implantation for idiopathic hypertrophic pachymeningitis with bilateral profound hearing loss: A case report.
Idei K; Kitamura M; Shimanuki MN; Hosoya M; Tsuzuki N; Hasebe N; Nishiyama T; Ozawa H; Oishi N
Medicine (Baltimore); 2023 Nov; 102(47):e36124. PubMed ID: 38013369
[TBL] [Abstract][Full Text] [Related]
44. [Idiopathic hypertrophic cranial pachymeningitis diagnosed after venous thrombosis].
García-Iñigo P; Paniagua-Escudero JC; de Castro-García FJ; Díez-Hernández JC
Rev Neurol; 2005 Jul 1-15; 41(1):34-6. PubMed ID: 15999328
[TBL] [Abstract][Full Text] [Related]
45. [A case of bilateral ophthalmoplegia caused by focal idiopathic hypertrophic pachymeningitis on the anterior cranial fossa].
Teramoto H; Hara M; Morita A; Kamei S
Rinsho Shinkeigaku; 2015; 55(1):33-6. PubMed ID: 25672863
[TBL] [Abstract][Full Text] [Related]
46. IgG4-related hypertrophic pachymeningitis with chronic subdural haematoma.
Lichtblau N; Aliaga-Arias J; Kalaitzoglou D; Bodi I; Ashkan K; Bhangoo R; Vergani F; Joe D; Stanton B; Galloway J; Carlton-Jones L; Lavrador JP
Pract Neurol; 2023 Oct; 23(5):441-445. PubMed ID: 37460210
[TBL] [Abstract][Full Text] [Related]
47. Idiopathic hypertrophic cranial pachymeningitis masquerading as Tolosa-Hunt syndrome.
Muthukumar N; Senthilbabu S; Usharani K
J Clin Neurosci; 2005 Jun; 12(5):589-92. PubMed ID: 16051099
[TBL] [Abstract][Full Text] [Related]
48. Idiopathic hypertrophic pachymeningitis: an autoimmune IgG4-related disease.
De Virgilio A; de Vincentiis M; Inghilleri M; Fabrini G; Conte M; Gallo A; Rizzo MI; Greco A
Immunol Res; 2017 Feb; 65(1):386-394. PubMed ID: 27592235
[TBL] [Abstract][Full Text] [Related]
49. Idiopathic hypertrophic cranial pachymeningitis associated with hydrocephalus and myocarditis: remarkable steriod-induced remission of hypertrophic dura mater.
Tanaka M; Suda M; Ishikawa Y; Fujitake J; Fujii H; Tatsuoka Y
Neurology; 1996 Feb; 46(2):554-6. PubMed ID: 8614532
[TBL] [Abstract][Full Text] [Related]
50. Idiopathic hypertrophic cranial pachymeningitis successfully treated with weekly subcutaneous methotrexate.
Ruiz-Sandoval JL; Bernard-Medina G; Ramos-Gómez EJ; Romero-Vargas S; Gutiérrez-Ureña S; González-Cornejo S; Chiquete E
Acta Neurochir (Wien); 2006 Sep; 148(9):1011-4. PubMed ID: 16614804
[TBL] [Abstract][Full Text] [Related]
51. [Case of Takayasu arteritis accompanying hypertrophic pachymeningitis].
Nishikawa S; Kawaguchi N; Fujimori J
Rinsho Shinkeigaku; 2015; 55(12):940-2. PubMed ID: 26511027
[TBL] [Abstract][Full Text] [Related]
52. An Update on Idiopathic Hypertrophic Cranial Pachymeningitis for the Headache Practitioner.
Charleston L; Cooper W
Curr Pain Headache Rep; 2020 Aug; 24(10):57. PubMed ID: 32803475
[TBL] [Abstract][Full Text] [Related]
53. [Chronic hypertrophic pachymeningitis: 2 clinical cases are presented].
Sánchez Medina Y; Triana Pérez A; Domínguez Baez J; Gómez Perals LF; Pérez del Rosario PA
Neurocirugia (Astur); 2013; 24(2):82-7. PubMed ID: 23206857
[TBL] [Abstract][Full Text] [Related]
54. Tl-201 uptake in chronic hypertrophic pachymeningitis.
Ohta H; Takeuchi H; Suzuki T; Shintaku M
Clin Nucl Med; 2003 Mar; 28(3):252-3. PubMed ID: 12592147
[No Abstract] [Full Text] [Related]
55. Focal status epilepticus as a manifestation of idiopathic hypertrophic cranial pachymeningitis.
Navalpotro-Gómez I; Vivanco-Hidalgo RM; Cuadrado-Godia E; Medrano-Martorell S; Alameda-Quitllet F; Villalba-Martínez G; Roquer J
J Neurol Sci; 2016 Aug; 367():232-6. PubMed ID: 27423594
[TBL] [Abstract][Full Text] [Related]
56. Idiopathic hypertrophic cranial pachymeningitis manifested by transient ischemic attack.
Fan Y; Liao S; Yu J; Ling L; Hou Q; Xing S; Zeng J
Med Sci Monit; 2009 Dec; 15(12):CS178-81. PubMed ID: 19946239
[TBL] [Abstract][Full Text] [Related]
57. Hypertrophic Pachymeningitis of the Internal Auditory Canal Induced by a Labyrinthine Fistula Complicated With Cholesteatoma.
Park KS; Shin BJ; Jang CH
Ear Nose Throat J; 2022 Sep; 101(8):NP321-NP323. PubMed ID: 33215535
[TBL] [Abstract][Full Text] [Related]
58. Idiopathic hypertrophic cranial pachymeningitis treated by oral methotrexate: a case report and review of literature.
Bosman T; Simonin C; Launay D; Caron S; Destée A; Defebvre L
Rheumatol Int; 2008 May; 28(7):713-8. PubMed ID: 18094971
[TBL] [Abstract][Full Text] [Related]
59. Hypertrophic pachymeningitis as a result of a retropharyngeal inflammatory pseudotumor: case report.
Matsumoto K; Natori Y; Hirokawa E; Iwaki T
Neurosurgery; 2002 Oct; 51(4):1061-4; discussion 1064-5. PubMed ID: 12234417
[TBL] [Abstract][Full Text] [Related]
60. Clinical, imaging features and treatment response of idiopathic hypertrophic pachymeningitis.
Yao Y; Xu Y; Li X; Song T; Xu W; Duan Y; Liu Y; Zhang X; Tian DC
Mult Scler Relat Disord; 2022 Oct; 66():104026. PubMed ID: 35868153
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
